Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy

Autor: Francesco Versaci, Annamaria Pinto, Mariangela Peruzzi, Giuseppe Biondi-Zoccai, Giorgio Sesti, Enrica Procaccini, Giandomenico Neri, Luigi Uccioli, Maurizio Vetere, Francesco Nudi
Rok vydání: 2016
Předmět:
Databases
Factual

medicine.medical_treatment
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
030204 cardiovascular system & hematology
dombination
0302 clinical medicine
middle aged
coronary artery disease
diabetes mellitus
hypoglycemic agents
ischemia
myocardial perfusion scintigraphy
aged
chi-square distribution
coronary angiography
databases
factual

diabetes mellitus
type 2

drug therapy
dombination

female
humans
insulin
male
metformin
multivariate analysis
myocardial ischemia
myocardial perfusion imaging
odds ratio
predictive value of tests
retrospective studies
risk factors
severity of illness index
sulfonylurea compounds
treatment outcome
tomography
emission-computed
single-photon
pharmacology
cardiology and cardiovascular medicine
medicine.diagnostic_test
drug therapy
Metformin
type 2
factual
Cardiology
Drug Therapy
Combination

Cardiology and Cardiovascular Medicine
Perfusion
medicine.drug
medicine.medical_specialty
databases
030209 endocrinology & metabolism
03 medical and health sciences
Myocardial perfusion imaging
Pharmacotherapy
Internal medicine
Diabetes mellitus
Severity of illness
medicine
Tomography
Emission-Computed
Single-Photon

Pharmacology
business.industry
Insulin
Type 2 Diabetes Mellitus
medicine.disease
Diabetes Mellitus
Type 2

business
Zdroj: Journal of Cardiovascular Pharmacology. 68:162-170
ISSN: 0160-2446
Popis: Hypoglycemic agents differ in mechanism, efficacy, and profile. However, there is uncertainty on their impact on myocardial perfusion. We thus aimed to investigate whether individuals with type 2 diabetes mellitus treated with different drug classes exhibit different perfusion patterns at myocardial perfusion scintigraphy (MPS).We queried our administrative database for patients with diabetes mellitus without prior or recent myocardial infarction. The primary objective was to compare the severity and extent of ischemia at MPS, distinguishing patients according to management strategy. A total of 7592 patients were included [2336 (31%) on diet, 3611 (48%) on metformin, 749 (10%) on sulfonylureas, 449 (6%) on metformin plus sulfonylureas, 447 (6%) on metformin plus insulin]. Unadjusted analyses and analyses adjusting for baseline features suggested that sulfonylureas alone or in combination were associated with more severe ischemia than nonsulfonylurea regimens (P0.05), whereas combination regimens including metformin were associated with more extensive myocardial ischemia than the other regimens (P0.05 for both). However, no significant difference disfavoring either metformin or sulfonylurea regimens persisted after multivariable adjustment for baseline, stress, and angiographic characteristics (all P0.05).Several significant differences in baseline, stress, and scintigraphic features appear evident in patients with diabetes mellitus receiving different hypoglycemic agents or regimens.
Databáze: OpenAIRE